Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Psoriasis Market Growth Performance Trended Historically, And What Lies Ahead?
The size of the psoriasis industry has seen substantial growth in the past few years. It is predicted to increase from $26.56 billion in 2024 to $29.5 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. Factors such as epidemiology, increased patient awareness and education, and advancements in healthcare infrastructure and accessibility have contributed to the growth seen in the historical period.
What Is the Forecast for the Psoriasis Market Size Through 2029?
The market for psoriasis is set for substantial expansion in the coming years, projected to reach $42.34 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. This growth during the predicted period is due to several factors including regulatory authorizations, patient choices, an aging demographic, heightened awareness, and the rollout of new treatments. Key trends anticipated during this period encompass advancements in research and development, biologics and targeted therapies, oral small molecule therapies, custom-tailored medicine, digital healthcare and telemedicine, patient-focused care, biosimilars, as well as the incorporation of artificial intelligence and machine learning.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp
What are the Key Market Players in Psoriasis Market and How They’re Evolving?
Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy’s Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy
What Are the Primary Growth Drivers in the Psoriasis Market?
An increase in the number of individuals suffering from psoriasis is pushing the growth of the Psoriasis market. Psoriasis results from a combination of factors including the immune system, genetics, and environmental conditions. The primary contributors to the recent surge in psoriasis cases are changes in climate, stress, and poor lifestyle choices. Data from the World Psoriasis Day consortium suggests that psoriasis affects 125 million people worldwide, accounting for 2 to 3% of the global population. Consequently, the escalating prevalence of psoriasis is anticipated to stimulate the expansion of the psoriasis market throughout the forecast period.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp
What Are the Leading Segments in the Global Psoriasis Industry?
The psoriasis market covered in this report is segmented –
1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Drug Types: Small molecules, Biologics
3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
4) By Route Of Administration: Oral, Tropical, Injectable
5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce
Subsegments:
1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)
2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)
3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)
4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)
What Are the Key Market Trends in the Psoriasis Industry?
The practice of combination therapy is a rising trend within the psoriasis market. This refers to the simultaneous use of two separate psoriasis treatments. Outcomes are generally better when two medications with varied mechanisms of action are teamed up in combination therapy, as opposed to relying on monotherapy, or the utilization of a solitary drug. Research indicates that combination therapy alleviates the symptoms of psoriasis more effectively and has less side effects than a single therapy. A prime example of combination therapy specifically for active psoriatic arthritis (PsA) is the pairing of taltz (ixekizumab) with methotrexate, a development courtesy of Eli Lilly and Company.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
What Is the Regional Outlook for the Psoriasis Market?
North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414
This Report Delivers Insight On:
1. How big is the psoriasis market, and how is it changing globally?
2. Who are the major companies in the psoriasis market, and how are they performing?
3. What are the key opportunities and risks in the psoriasis market right now?
4. Which products or customer segments are growing the most in the psoriasis market?
5. What factors are helping or slowing down the growth of the psoriasis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model